Pharmacopsychiatry

Papers
(The H4-Index of Pharmacopsychiatry is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
70
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?26
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study24
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study22
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries20
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System17
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation16
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination15
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model15
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety13
The Mini-TRH Test13
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study12
0.21988487243652